Clinical Trial Update: Efficacy of Retreatments With Intravitreal Bevacizumab [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating retreatments with intravitreal bevacizumab for age-related macular degeneration has been terminated; no final efficacy results are repo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Age Related Macular Degeneration, Choroidal Neovascularization | Phase 3 | Status: TERMINATED